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E-mail address: Walden.Ai@uscmed.sc.edu (W. Ai)We aimed to examine the physical interaction between CtBPs and KLF4 and the potential
importance of this interaction. Co-immunoprecipitation indicated that CtBP1 indeed interacted
with KLF4. This was supported by the co-localization of both KLF4 and CtBP1 in the promoter
regions of KLF4 downstream target genes. In addition, overexpression of CtBP1 signiﬁcantly
decreased KLF4-mediated transcriptional activation in both an artiﬁcial (pGL5) and genuine (IAP
and Keratin-4) reporter system. Mutations in the potential CtBP binding motif in KLF4 were
accompanied by loss of the inhibitory effect of CtBP1 in the reporter assay and of the physical inter-
action with CtBP1. Overall, our results suggest that CtBPs attenuate KLF4-mediated transcriptional
activation through the physical interaction with KLF4.
Structured summary:
MINT-7261981, MINT-7261995: KLF4 (uniprotkb:O43474) physically interacts (MI:0915) with CTBP1 (uni-
protkb:Q13363) by anti tag coimmunoprecipitation (MI:0007)
MINT-7262008, MINT-7262023: CTBP1 (uniprotkb:Q13363) physically interacts (MI:0915) with KLF4 (uni-
protkb:O43474) by anti bait coimmunoprecipitation (MI:0006)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Regulation of gene expression is a fundamental cellular pro-
cess. Critical to the control of gene expression are transcription
factors that bind to speciﬁc DNA sequences and subsequently
modulate gene transcription. A family of the C2H2-zinc ﬁnger
proteins exhibits homology to the Drosophila melanogaster seg-
mentation gene product, Krüppel 3, hence the name Krüppel-like
factors (KLFs). KLFs play important roles in many fundamental
biologic processes, including development, proliferation, differen-
tiation and apoptosis [1]. One member of this family, Krüppel-like
factor 4 (KLF4), also known as gut-enriched Krüppel-like factor
(GKLF), was found to be highly expressed in epithelial cells of
many tissues, including small intestine and skin [2]. In these tis-
sues, by directly binding to CACCC motif in the promoter region
of its target genes, KLF4 transcriptionally regulates its target genes
resulting in inhibition of proliferation and promotion of terminal
differentiation [3,4].chemical Societies. Published by E
Pathology, Microbiology and
edicine, 6439 Garners Ferry
733 1515.
.C-terminal binding proteins (CtBPs) family proteins are modu-
lators of several essential cellular processes [5]. Vertebrate gen-
omes code for two related proteins, CtBP1 and CtBP2. CtBP
family proteins are highly conserved. The founding member of this
family, CtBP1 was discovered as a cellular protein that interacted
with the C-terminus of adenovirus E1A proteins [6]. CtBPs function
as transcriptional co-repressors. A large number of sequence-
speciﬁc DNA-binding transcriptional repressors of Drosophila and
mammalian species mediate their activity in a CtBP-dependent
manner [7]. At present, more than thirty different vertebrate
transcriptional regulators have been reported to modulate their
activity through recruitment of CtBPs.
The various DNA-binding repressors recruit CtBP through a
conserved CtBP binding motif, a Pro-X-Asp-Leu-Ser (PXDLS)
CtBP interaction domain (Fig. 1A) originally identiﬁed in adenovi-
rus E1A protein [8]. A PYDLA motif was also found in the N-termi-
nal region of human KLF4 protein (aa 53–57, Fig. 1A). In the
present study, we aimed to examine the physical interaction
between CtBPs and KLF4 and the potential importance of this
interaction. Our ﬁndings suggest that CtBPs attenuate KLF4-med-
iated transcriptional activation, and this attenuation is most
likely fulﬁlled through directly interacting with KLF4 via PYDLA
motif.lsevier B.V. All rights reserved.
Fig. 1. CtBP1 associated with KLF4. (A) The sequences of CtBP consensus binding motif, potential hKLF4 CtBP binding motif and the mutant hKLF4 binding motif. (B) Co-IP and
Western blot analysis to examine the physical interaction between pMyc-KLF4 and pFLAG-CtBP1. Transient transfections using AGS cells, Co-IP, and Western blotting were
performed as described in Section 2. (C) Endogenous Co-IP and Western blot analysis. Protein extracts from AGS cells and anti-KLF4 and anti-CtBP1 antibodies were used for
the assay.
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2.1. Cell culture
AGS cells and KLF4 Mouse embryo ﬁbroblasts (MEFs) (KLF4+/,
KLF4/) cells or CtBP MEFs (CtBP+/, CtBP/) cells were cultured
in complete Dulbecco’s modiﬁed Eagle’s medium (DMEM) simi-
larly as described [9]. Human colon cancer HCT 116 cells were
grown in complete McCoy’s medium.
2.2. Plasmids
Plasmids used for artiﬁcial promoter reporter assay were as fol-
lows: pGL5-Luc reporter plasmid, pM vector, pM/KLF4, pFLAG vec-
tor, pFLAG-CtBP1, pFLAG-CtBP2 (from Dr. G. Chinnadurai), and pM/
KLF4FM, a mutated version of KLF4 that harbors point mutations in
potential CtBP binding motif (Fig. 1A), IAP and KRT luciferase
reporter constructs (from Drs C. Liu and A. Rustgi, respectively),
pcDNA 3/Myc-His B vector (pMyc), pMyc-KLF4, and pMyc-KLF4FM.
All the cloned plasmids have been sequence conﬁrmed.
2.3. Transient transfection and co-immunoprecipitation assays
Plasmids were transfected into indicated cells using Lipofect-
amine 2000 (Invitrogen). Proteins were extracted, followed by
Western blotting analysis using mouse anti-FLAG tag (SIGMA), rab-
bit anti-Myc tag (ABR), rabbit anti-human b-actin (SIGMA) anti-
bodies. Endogenous Co-IP experiments were similarly performed
using an anti-KLF4 antibody (Santa Cruz) and an anti-CtBP1 anti-
body (Santa Cruz) together with IgG controls.
2.4. Chromatin immunoprecipitation (ChIP) assays
CHIP assays using AGS or KLF4 MEFs cells were performed as
previously described [9]. Extracted DNA samples from transfectedAGS cells were used to amplify promoter fragments of KLF4 target
genes. The promoter fragments of target human genes were
ampliﬁed and the primer pairs were as follows: CCND1 (Upper:
50-TCTACACCCCCAACAAAACCAA-30; Lower: 50-ACTCTTCGGGCTGC
CTTCCTAC-30), p21 (Upper: 50-GACCGGCTGGCCTGCTGGAACT-30;
Lower: 50-GCACGCTTGGCTCGGCTCGGCTCTGG-30), IAP (Upper:
50-GGG CCC ATG GAA AAC AGA CTC A-30; Lower: 50-AGACGCGTTG
CCACTCCTTCAT-30), Laminin a1 (Upper: 50-GGCAAACAAAGTCGG
GAACAAG-30; Lower: 50-TAGGAGGTGGGC AGAGAAGGTG-30), HDC
(Upper: 50-GAACTGAGGGCTCTTTTACG-30; Lower: 50-CAGTGTGG
GCCCTTTATTTA-30) and Keratin-4 (Upper: 50-GATCGCCACCTA
CCGCAAACTG-30; Lower: 50-GAGCCGGAGCCAAAGCCACTAC-30). Ex-
tracted DNA samples from transfected KLF4 MEFs cells were used
to amplify promoter fragments of KLF4 targets mouse genes. The
primer pairs used were as follows: CCND1 (Upper: 50-CCCCC
AGCGAGGAGGAA-30; Lower: 50-AGGCGGACCCATTGCTTAGA-30),
IAP (Upper: 50-CACCCAACCTGCAGGAGACAT A-30; Lower: 50-GCT
AGGGAACCAAGGCACCAG-30), p21 (Upper: 50-CTG CCT CCC GAG
TGC TGT G-30; Lower: 50-GGG GCC CCG ATG GTA CCG-30), HDC
(Upper: 50-TGGCAATTCTTCCCCCTTACG-30; Lower: 50-GCTCCTGCC
CTGGCTTCTCTAT-30) and Keratin-4 (Upper: 50-CTTGGCCTGGG
TAGCGGTTTTT-30; Lower: 50-TGATGGTGGCGGAAGAGGTGAT-30).
PCR products were analyzed on 2.0% agarose gels containing ethi-
dium bromide (0.25 lg/ml).
2.5. Transient cotransfection and dual luciferase assays
HCT 116 cells were used for transient co-transfection and dual
luciferase assay using a previous published protocol [9].
2.6. Total RNA isolation and quantitative real-time PCR
CtBP MEFs cells were grown to 80% conﬂuence in six-well plates
and then the culture medium was replaced by DMEM without FBS
for another 1 h, 2 h, 4 h and 8 h, respectively. RNA samples were
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Fig. 3. CtBPs attenuated KLF4-mediated transcriptional activation. (A) A diagram of
an artiﬁcial pGL5-Luciferase reporter system was shown, where KLF4 is recruited to
the proximal promoter region to activate transcription. (B) Overexpression of CtBP1
and CtBP2 signiﬁcantly reduced KLF4-mediated transcriptional activation. Tran-
sient co-transfections with pGL5 reporter construct and pM vector, pM/KLF4, pM/
KLF4 and pFLAG-CtBP1 and pFLAG-CtBP2 with different combination were
performed in HCT 116 cells, followed by dual luciferase assay as described in
Section 2. Means ± S.D. for three independent experiments were shown.
G. Liu et al. / FEBS Letters 583 (2009) 3127–3132 3129then prepared, followed by the complimentary DNA (cDNA) syn-
thesis, and quantitative real-time PCR (qRT-PCR) analysis using
the following primer pairs of mouse origin: KLF4-5RT (50 CAAGTCC
CGCCGCTCCATTACCAA 30) and KLF4-3RT (50 CCACAGCCGTCCCAGT
CACAGTGG 30) for KLF4 gene, IAP-5RT (50-CGCCTATCTCTGT
GGGGTCAAG-30) and IAP-3RT (50-TAGGTGCCGGCTGGAGAGG-30)
for the IAP gene, Keratin-4-RT 5 (50 CTTGGCCTGGGTAGCGGTTTTT
30) and Keratin-4-RT 3 (50 TGATGGTGGCGGAAGAGGTGAT 30) for
Keratin-4 gene, CCND1-RT 5 (50 AGCCCCAACAACTTCCTCTCCT 30)
and CCND1-RT 3 (50 TTCCCCCTCCTCCTCAGTGG 30) for CCND1 gene,
and GAPDH-5RT (50 GACATCAA GAAGGTGGTGAAGC 30) and GAP
DH-3RT (50 GTC CACCACCCTGTTGCTGTAG 30) for GAPDH gene.
Transcript abundances were ﬁrst normalized to the levels of GAPDH
RNA, and then to their own levels at the 0 time point in the presence of
CtBP.
3. Results and discussion
3.1. KLF4 interacts with CtBP1
Two Krüppel-like family members, BKLF/KLF3 and KBKF3/KLF8
have been reported to interact with CtBP through a PVDLT motif,
which is highly similar to CtBP consensus binding motif PXDLS
[10,11]. Sequence analysis revealed a potential CtBP binding motif
at the N-terminal of KLF4 (PYDLA, Fig. 1A). To test the putative
KLF4 and CtBP1 interaction, Co-immunoprecipitation was per-
formed. AGS cells, human gastric cancer cells where KLF4 is ex-
pressed, were cotransfected with pMyc-KLF4 and pFLAG-CtBP1
expression vectors. Cell lysates from transfected cells were then
immunoprecipitated with an anti-Myc antibody and an anti-FLAG
antibody followed by immunoblotting with an anti-FLAG antibody
and an anti-Myc antibody, respectively. Immunoprecipitation of
pMyc-KLF4 was accompanied by detection of pFLAG-CtBP1, and
vice versa (Fig. 1B). Consistently, endogenous Co-IP also showed
the physical association between KLF4 and CtBP1 (Fig. 1C). Taken
together, these results indicated that CtBP1 interacts with KLF4.
3.2. KLF4 and CtBP1 co-localized in promoter regions of some KLF4
downstream target genes
CtBPs have been shown to act as transcriptional corepressor of
many transcription factors that are involved in important signaling
transduction pathways, including transforming growth factor beta
(TGF-beta) signaling [12,13] and Notch signaling [14]. If CtBP1 in-
deed interacts with KLF4, it is expected that both proteins colocal-Fig. 2. CtBP1 co-localized with KLF4 on the promoters of KLF4 downstream target gen
vectors. CHIP assays were performed to examine the occupancy of KLF4 and CtBP1 on the
and LAMA1. (B) pMyc-KLF4, pFLAG-CtBP1 KLF4, and the respective vectors with differen
CtBP1 on the promoters of IAP, KRT 4, p21, CCND1, and HDC were examined to test theize on the promoter regions of KLF4 downstream target genes. To
test this possibility, chromatin immunoprecipitation assays were
performed using a colon cancer cell line (HCT 116 cells). These cells
were transfected with pMyc-KLF4 or pFLAG-CtBP1 together with
vector controls, followed by ChIP assays using an anti-Myc or an
anti-FLAG antibody. As shown in Fig. 2A, DNA fragments of pro-
moter regions of some KLF4 human target genes, including Intesti-
nal alkaline phosphatase (IAP) [15], Keratin-4 (KRT 4) [16], p21
[17], Cyclin D1 (CCND1) [18], histidine decarboxylase (HDC) [19],
and Laminin a1 (LAMA1) [20], were ampliﬁed from both Myc IPs
using pMyc-KLF4-transfected elutes and FLAG IPs using pFLAG-
CtBP1-transfected elutes. Under the same condition, no bands were
seen from control vectors-transfected elutes, indicating that KLF4
and CtBP1 both are localized on the promoter regions of thesees. (A) AGS cells were transfected by pMyc-KLF4, pFLAG-CtBP1, and the respective
promoters of KLF4 downstream target genes, including IAP, KRT 4, p21, CCND1, HDC
t combinations were transfected into KLF4 null MEFs for CHIP assays. Occupancy of
dependence of KLF4.
3130 G. Liu et al. / FEBS Letters 583 (2009) 3127–3132KLF4 target genes. To further examine the binding of CtBP1 with
the promoters are dependent on KLF4, KLF4 knockout MEFs were
used for CHIP assays. As shown in Fig. 2B, whereas DNA fragments
of promoter regions of some KLF4 mouse target genes, including
IAP, KRT 4, p21, CCND1, and HDC, were ampliﬁed after KLF4 trans-
fection. These fragments were barely seen from FLAG IPs using
pFLAG-CtBP1-transfected elutes without KLF4 transfection. How-
ever, after pMyc-KLF4 and pFLAG-CtBP1 co-transfection, these
bands are robustly ampliﬁed, indicating that CtBP1 binding with
these promoters are KLF4-dependent, which further supports the
interaction between CtBP1 and KLF4.
3.3. CtBPs attenuated KLF4-mediated transcriptional activation
To analyze the role of CtBP1 in KLF4-mediated gene transcrip-
tion regulation, we ﬁrst used an artiﬁcial reporter system, where
KLF4 was recruited to the promoter region to activate transcription
(Fig. 3A) [9], to perform a reporter assay. Since CtBP1 and CtBP2
have overlapping functions [21], we used both CtBP1 and CtBP2
expression constructs. As seen in Fig. 3B, while CtBP1 and CtBP2
slightly activated the promoter activity, they signiﬁcantly compro-
mised KLF4-mediated transcriptional activation (about 50% de-
crease). Interestingly, when we introduced mutations in CtBP
binding motif within KLF4, it did not signiﬁcantly inﬂuence KLF4-
induced transcriptional activation. However, either CtBP1 or CtBP2
attenuated KLF4-mediated activity, suggesting that CtBP binding0
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Fig. 4. CtBPs attenuated KLF4-mediated IAP and KRT 4 reporter activation. Similar to Fig.
of pGL5 reporter. (C) Mutations in CtBP binding motif in KLF4 abolished interaction betw
harbors mutations in CtBP binding motif were co-transfected with pFLAG-CtBP1 and co
KLF4 and CtBP1 as described in Fig. 1B.motif in KLF4 is critical for CtBPs to regulate the activity of KLF4.
Similarly, when the reporter constructs of two KLF4 target genes,
including IAP and KRT 4, were used in the same assay, CtBP1 signif-
icantly compromised KLF4-mediated reporter activation. In addi-
tion, when the same mutant KLF4, which harbors mutations in
CtBP binding motif, was used, CtBP1 no longer inhibited KLF4-
mediated reporter activation (Fig. 4A and B). All these data suggest
that CtBP inhibited KLF4-mediated transcriptional activation
through CtBP binding motif. In order to examine if the mutant
KLF4 used in the reporter assay lost its ability to interact with
CtBP1, co-immunoprecipitation assay was performed. As shown
in Fig. 4C, while wild-type pMyc-KLF4 was co-immunoprecipitated
with pFLAG-CtBP1, the mutant KLF4 was not able to do so, indicat-
ing that mutations in CtBP binding motif in KLF4 abolished the
physical interaction between KLF4 and CtBP1.
3.4. Expression of KLF4 downstream target genes is dependent on the
status of CtBPs
Overexpression of CtBP1 or CtBP2 or in combination of both
in vitro resulted in no signiﬁcant changes of KLF4 expression (data
not shown). We then serum-starved the cells, which is an efﬁcient
way to induce KLF4 expression. In order to further examine the
importance of physical interaction between KLF4 and CtBPs, we
measured the expression of KLF4 downstream target genes by
quantitative RT-PCR (qRT-PCR) after KLF4 upregulation and in theC
3B except IAP promoter reporter (A) or KRT 4 reporter (B) construct was used instead
een KLF4 and CtBP1. Wild-type (pMyc-KLF4) and mutant KLF4 (pMyc-KLF4M) that
-immunoprecipitation assays were performed to examine the interaction between
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Fig. 5. Expression of KLF4 downstream target genes is dependent on the status of CtBPs. CtBP+/ and CtBP/ MEFs were cultured in the presence and absence of serum for 1–
8 h. Total RNA samples were prepared at each time point followed by quantitative RT-PCR analysis to examine the expression levels of KLF4 (A), KRT 4 (B), p21 (C), and IAP
(D). Transcript abundances were normalized to levels of GAPDH RNA and were expressed as relative values. Means ± S.D. for three independent experiments were shown.
G. Liu et al. / FEBS Letters 583 (2009) 3127–3132 3131presence and absence of CtBP. CtBP+/ MEFs and CtBP/ (CtBP1–
CtBP2–) MEFs were serum-starved for 1 h, 2 h, 4 h and 8 h. The
RNA samples from these serum-starved and normally cultured
cells were used in qRT-PCR to study the changes in RNA levels of
KLF4 and some of its target genes. KLF4 RNA levels of both
CtBP/ and CtBP+/ MEFs were steadily increased when cells were
serum-starved from 1 h to 8 h, with the highest RNA level at 8 h
time point (4.59-fold and 12.83-fold increase, respectively, when
compare to that of 0 h time point, Fig. 5A). Consistent with the
upregulation of KLF4 upon serum starvation, KRT 4 mRNA levels
were similarly increased from 1 h to 8 h serum starvation. How-
ever, while the basal levels of KLF4 and KRT 4 are very similar
when cells are not serum-starved in both CtBP/ and CtBP+/ cells,
with serum starvation, the fold increase of KRT 4 in CtBP/ MEFs
are much higher than CtBP+/ MEFs (Fig. 5B), that is signiﬁcantly
different from KLF4 increase upon serum starvation. It appears that
fold increase are very similar in both CtBP/ and CtBP+/ MEFs
(Fig. 5A). Although there might be other mechanisms for this dif-
ference, based on our studies we would argue that CtBPs down-
regulate KLF4-mediated transcriptional activation. In the absence
of CtBP, this inhibitory effort is relieved, resulting in the upregula-
tion of the downstream target genes such as KRT 4. A similar obser-
vation was also seen for p21, another KLF4 target gene (Fig. 5C). It
should be noted that not all KLF4 downstream target gene behave
the same as KRT 4 and p21, such as IAP and CCND1 (Fig. 5D and
data not shown), which suggests the complexity of transcriptional
regulation mediated by KLF4. For example, KLF3, another known
CtBP binder [22], is activated by KLF4 [23] which also binds CtBP
from our current study. It is likely that the CtBP-dependent effects
may be mediated through KLF3 rather than KLF4. On the other
hand, we cannot exclude the possibility that KLF4 mediates the
repression. Furthermore, KLF4 downstream target genes are not
necessarily solely, or exclusively KLF4 targets. KLF3, which can be
activated by KLF4, also represses KLF8, and KLF8 is also involvedin the regulation of KLF4, so the situation is complex, and it may
be difﬁcult to separate the effects [24,25]. The existence of such
cross-regulation and potential redundancy between KLF family
members makes it difﬁcult to precisely explain how KLF4 represses
gene expression through CtBPs.
In summary, our current study provides evidence of directly
interaction between KLF4 and CtBPs. It appears that this interac-
tion is critical for CtBPs to attenuate KLF4-mediated transcriptional
activation, since mutations within the CtBP binding motif in KLF4
not only abrogated the physical interaction between KLF4 and
CtBP1, but also abolished the inhibitory effort of CtBPs. At the pres-
ent time, the physiological importance of the interaction remains
unknown. However, given the importance of the downstream tar-
get of KLF4, including p21 and CCND1, in the cell cycle control and
tumor progression [26], it is likely that CtBP-mediated attenuation
of KLF4 activity plays a critical role in these processes. Recently,
KLF4 has been shown to have important functions in stem cell biol-
ogy [27,28]. On the other hand, CtBP partially mediated the effect
of TCF3 in maintaining pluripotency and self-renewal of mouse
embryonic stem cells [29]. It will be very interesting to examine
if the regulation of KLF4 by CtBPs plays any roles in stem cell
self-renewal or differentiation.
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